Charlesson's Grant

Charlesson raised a round of funding on June 29, 2010. Investors include i2E.

Charlesson develops pharmaceuticals to treat ocular conditions. Charlesson also has retinal surgeons and scientists on staff who perform ophthalmic preclinical experiments for pharmaceutical companies…

Articles about Charlesson's Grant: